• Users Online: 75
  • Print this page
  • Email this page

    Article Cited by others

REVIEW ARTICLE

Management of macular edema due to central retinal vein occlusion – The role of aflibercept

Rhoades William, Dickson Drew, Nguyen Quan Dong, Do Diana V

Year : 2017| Volume: 7| Issue : 2 | Page no: 70-76

   This article has been cited by
 
1 Efficacy and Safety of an Aflibercept Treat-and-Extend Regimen in Treatment-Naïve Patients with Macular Oedema Secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial
Jose Garcia-Arumi,Francisco Gómez-Ulla,Navea Amparo,Enrique Cervera,Alex Fonollosa,Luis Arias,Javier Araiz,Juan Donate,Marta Suárez de Figueroa,Lucia Manzanas,Jaume Crespí,Roberto Gallego
Journal of Ophthalmology. 2018; 2018: 1
[Pubmed]  [Google Scholar] [DOI]
2 Comparative efficacy of bevacizumab, ranibizumab, and aflibercept for treatment of macular edema secondary to retinal vein occlusion: a systematic review and network meta-analysis
Sermsiri Sangroongruangsri,Tanapat Ratanapakorn,Olivia Wu,Thunyarat Anothaisintawee,Usa Chaikledkaew
Expert Review of Clinical Pharmacology. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
3 Effects of ripasudil, a ROCK inhibitor, on retinal edema and nonperfusion area in a retinal vein occlusion murine model
Yoshifumi Hida,Shinsuke Nakamura,Anri Nishinaka,Yuki Inoue,Masamitsu Shimazawa,Hideaki Hara
Journal of Pharmacological Sciences. 2018;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article